Suppr超能文献

绿茶对糖尿病大鼠肾小管的影响。

Effect of green tea on kidney tubules of diabetic rats.

作者信息

Renno Waleed M, Abdeen Suad, Alkhalaf Mousa, Asfar Sami

机构信息

Departments of Anatomy, Faculty of Medicine, Health Science Center, Kuwait University, PO Box 24923, Safat 13110, Kuwait.

出版信息

Br J Nutr. 2008 Sep;100(3):652-9. doi: 10.1017/S0007114508911533. Epub 2008 Feb 6.

Abstract

It has been documented that green tea (GT) and its catechin components improve renal failure and inhibit the growth of mesangial cells. In the present study we examined the long-term effect of GT extract on streptozotocin (STZ)-induced diabetic nephropathy and on the glycogen accumulation in the kidney tubules. Male Sprague-Dawley rats were randomly assigned to normal control groups (2, 6, 8 and 12 weeks) and five diabetic groups (n 10) of comparable age. A GT diabetic group received 16 % concentration of GT for 12 weeks post-diabetes induction as their sole source of drinking water. GT treatment significantly (P < 0.01) reduced the serum glucose, glycosylated protein, serum creatinine and blood urea N levels by 29.6 (sem 3.7), 22.7 (sem 5.2), 38.9 (sem 10) and 41.7 (sem 1.9) %, respectively, compared with the diabetic group of comparable age. In addition, the GT-treated group showed a significant 44 (sem 10.8) % higher creatinine clearance (Ccr) compared with the untreated diabetic group. Likewise, GT reduced the urea N, creatinine, glucose and protein excretion rates by 30 (sem 7.6), 35.4 (sem 5.3), 34.0 (sem 5.3) and 46.0 (sem 13.0) % compared with the 12 weeks diabetic group. Administration of GT to 12 weeks diabetic rats significantly (P < 0.001) prevented (99.98 (sem 0.27) % less) the accumulation of glycogen in the kidney tubules. These results indicate that in STZ diabetes, kidney function appears to be improved with GT consumption which also prevents glycogen accumulation in the renal tubules, probably by lowering blood levels of glucose. Therefore, GT could be beneficial additional therapy in the management of diabetic nephropathy.

摘要

已有文献记载,绿茶(GT)及其儿茶素成分可改善肾衰竭并抑制系膜细胞生长。在本研究中,我们检测了GT提取物对链脲佐菌素(STZ)诱导的糖尿病肾病以及肾小管中糖原积累的长期影响。将雄性Sprague-Dawley大鼠随机分为正常对照组(2、6、8和12周)以及五个年龄相当的糖尿病组(每组n = 10)。GT糖尿病组在糖尿病诱导后12周饮用16%浓度的GT作为其唯一饮用水来源。与年龄相当的糖尿病组相比,GT治疗使血清葡萄糖、糖化蛋白、血清肌酐和血尿素氮水平分别显著降低(P < 0.01)29.6(标准误3.7)%、22.7(标准误5.2)%、38.9(标准误10)%和41.7(标准误1.9)%。此外,与未治疗的糖尿病组相比,GT治疗组的肌酐清除率(Ccr)显著提高了44(标准误10.8)%。同样,与12周糖尿病组相比,GT使尿素氮、肌酐、葡萄糖和蛋白质排泄率分别降低了30(标准误7.6)%、35.4(标准误5.3)%、34.0(标准误5.3)%和46.0(标准误13.0)%。给12周龄糖尿病大鼠施用GT可显著(P < 0.001)预防(减少99.98(标准误0.27)%)肾小管中糖原的积累。这些结果表明,在STZ糖尿病中,饮用GT似乎可改善肾功能,这也可能通过降低血糖水平来预防肾小管中糖原的积累。因此,GT可能是糖尿病肾病管理中有益的辅助治疗方法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验